Robert Cincotta: Fetal Vulnerability in Anti-Ro/SSA and Anti-La/SSB Antibody-Positive Pregnancies
Robert Cincotta, Director and Founder at QUFW, shared a post on LinkedIn about a paper by Zeinab F. Saleh et al. published in AJOG:
“For years, one question has stayed with me.
Why do anti-Ro/SSA and anti-La/SSB antibodies which maybe present for decades in women with Lupus or Sjögren’s syndrome, leave the mother’s heart untouched, yet during a narrow window of fetal development can permanently damage a baby’s cardiac conduction system?
We know the outcome too well: irreversible complete heart block, pacing in infancy, lifelong consequences and sometimes, loss.
The devastation is real, yet strikingly selective.
Around 2% of antibody-positive pregnancies are affected. If a woman has had one affected child, the recurrence risk in a subsequent pregnancy rises to nearly 20%.
The explanation lies in fetal vulnerability.
During mid-gestation, the fetal conduction system is still forming. Maternal autoantibodies cross the placenta, trigger inflammation, and ultimately fibrosis of the AV node. The mature maternal heart with stable calcium channel expression and structural redundancy, simply isn’t susceptible in the same way.
That biology matters. Because it gives us a therapeutic foothold.
A recent AJOG expert review looks at clinical outcomes and safety evidence for hydroxychloroquine (HCQ) in pregnancy. Beyond its established role in lupus, HCQ is safe in pregnancy and significantly reduces recurrence of congenital heart block in anti-SSA/SSB positive pregnancies.
For me, the take home message isn’t just about a medication.
It’s about understanding why the fetus is uniquely vulnerable and how aligning therapy with developmental biology can change outcomes.”
Title: Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies
Authors: Zeinab F. Saleh, Emily C. Somers, Vivian C. Romero, Wendy Marder
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 10, 2026, 04:36Tess Kossow: Why I Created Nurture IVF Concierge After My Own Infertility Journey
-
Oct 10, 2026, 04:32Hosting the First Advanced Obstetric Surgical Skills Course – RCOG
-
Oct 10, 2026, 04:29Beyond IVF Laboratory Optimization: Addressing Patient Dropout – RBMO
-
Oct 10, 2026, 04:22Does Lifestyle Really Affect Fertility? – Montgomery Fertility Center
-
Oct 10, 2026, 04:20Mamoon Banat: Quick Recap of the 2026 CFAS Meeting in Calgary, Canada
-
Oct 8, 2026, 17:18Khalil Faaed: Vitrification Prevents Ice, but Does It Prevent Oocyte Damage?
-
Oct 8, 2026, 17:16Ritu Anand: Better Conversations Ultimately Lead to Better Care in Fertility
-
Oct 8, 2026, 17:14Mark Trolice: Excited to Speak at Women’s HealthX
-
Oct 8, 2026, 17:12Delighted to Welcome Dr. Róisín Mortimer – Waterstone Clinic-IVF and Fertility